4 Healthcare Stocks Bucking the Market Trend

In big news, the FDA rejected Xarelto, a drug co-developed by Johnson & Johnson (NYSE:JNJ) and Bayer. However, these stocks are helping the Healthcare (NYSE:XLV) sector despite the bad news. Long time Wall St. Cheat Sheet readers know to watch stock prices because Technicals on the Stock Chart are Strong’ is one of the ‘T’s in our CHEAT SHEET investing framework.

Johnson & Johnson (NYSE:JNJ) is among the sector price gainers, as its shares are trading at $64.52, up 45 cents (+0.7%) from the previous close of $64.07. Johnson & Johnson is a holding company involved in the research and development, manufacture and sale of a range of health care products.

Stock Price Performance: From July 8, 2011, to September 2, 2011, the stock price had fallen $2.90 (-4.3%) from $66.97 to $64.07. The stock price saw one of its best stretches over the last year between September 7, 2010 and September 20, 2010 when shares rose for 10 straight trading days, rising 5.8% (+$3.27). It saw one of its worst periods between July 22, 2011 and August 4, 2011 when shares fell for 10 straight trading days, falling 7.3% (-$4.84).

Pfizer Inc. (NYSE:PFE) is among the top price gainers in the sector. Its shares are trading at $18.57, up 12 cents (+0.6%) from the previous close of $18.46. Pfizer Inc. is a global pharmaceutical company which develops and manufactures prescription medications for humans and animals.

Stock Price Performance: From June 9, 2011, to September 2, 2011, the stock price had fallen $2.06 (-10%) from $20.52 to $18.46. The stock price saw one of its best stretches over the last year between April 21, 2011 and May 2, 2011 when shares rose for seven straight trading days, rising 6.2% (+$1.21). It saw one of its worst periods between July 6, 2011 and July 18, 2011 when shares fell for nine straight trading days, falling 5.5% (-$1.13).

Bristol-Myers Squibb Company (NYSE:BMY) is among the sector price gainers, as its shares are trading at $29.16, up 15 cents (+0.5%) from the previous close of $29.01. Bristol-Myers Squibb Company is a global company which develops, manufactures and sells pharmaceutical products.

Stock Price Performance: From August 5, 2011, to September 2, 2011, the stock price had risen $1.58 (5.8%) from $27.43 to $29.01. The stock price saw one of its best stretches over the last year between June 27, 2011 and July 7, 2011 when shares rose for eight straight trading days, rising 4.4% (+$1.23). It saw one of its worst periods between January 3, 2011 and January 11, 2011 when shares fell for seven straight trading days, falling 2.5% (-63 cents).

Perrigo Company (NASDAQ:PRGO) is among the top price gainers in the sector. Its shares are trading at $90.76, up 89 cents (+1%) from the previous close of $89.87. Perrigo Company is a global healthcare supplier which develops, manufactures and distributes over-the-counter and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients & pharmaceutical & medical diagnostic products.

Stock Price Performance: From August 5, 2011, to September 2, 2011, the stock price had risen $7.90 (9.6%) from $81.97 to $89.87. The stock price saw one of its best stretches over the last year between April 4, 2011 and April 15, 2011 when shares rose for 10 straight trading days, rising 10.9% (+$8.70). It saw one of its worst periods between April 27, 2011 and May 5, 2011 when shares fell for seven straight trading days, falling 6.3% (-$5.74).

More from The Cheat Sheet